D. Cirillo (Milan, Italy), V. Crudu (Chisinau, Republic of Moldova)
Isoniazid monoresistant tuberculosis in Israel: 2000-2008
D. Shitrit, L. Fuks, M. Kramer (Kfar Saba, Petach Tiqwa, Rehovot, Israel)
|   |
Dynamics and character of MBT drug resistance in a specialized urban TB hospital
L. Pankratova, E. Pereselentseva, L. Vlasova (Saratov, Russian Federation)
| |
Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova
A. Malic, E. Stratan, V. Crudu, N. Moraru, L. Carchilan, V. Lesan, A. Buga, G. Blagodeteleva (Chisinau, Republic Of Moldova)
| |
Validation of the MGIT 960 technique for 2nd line drug susceptibility testing (DST) of Mycobacterium tuberculosis
S. C. Hwang, Y. J Jung, W. Y. Jung, K. S. Lee, J. H. Park, S. S. Sheen, K. J. Park (Suwon, Republic Of Korea)
| |
Ten years of the multidrug-resistant tuberculosis treatment in the Thomayer Faculty Hospital, Prague
J. Kotrbova, M. Vasakova, E. Kopecka (Prague, Czech Republic)
| |
Beijing/w family of Mycobacterium tuberculosis in a major immigrant-receiving country: An emerging public health threat?
D. Langlois-Klassen, D. Kunimoto, L. D. Saunders, J. Boffa, L. Chui, R. Long (Edmonton, Canada)
| |
Standardized second-line anti-TB treatment of multidrug-resistant tuberculosis during pregnancy; maternal and neonatal safety and outcome
A. Moradi, P. Tabarsi, D. Mansouri, N. Mansouri (Tehran, Islamic Republic Of Iran)
| |
Factors preventing better treatment completion among MDR TB cases in a rich-resource setting
L. Anderson, S. Tamne, F. Droboniewski, I. Abubakar (London, United Kingdom)
| |
The management of MDR TB cases registered in the 4th sector of Bucharest during 2004-2006
M. Tigau, I. Dediu, R. Spataru, C. Didilescu, E. Ibraim (Bucharest, Romania)
| |
Characteristics and treatment outcome of MDR-TB in the Czech Republic
V. Bartu, E. Kopecka, M. Havelkova (Prague, Czech Republic)
| |
Prevalence of cross-resistance between rifampicin and rifabutin in Mycobacterium tuberculosis isolates in a tertiary care hospital in India
M. Kale, P. Khatavkar, S. Desai, M. Satpute, N. Telang (Pune, India)
| |
Rapid detection of Mycobacterium tuberculosis growth by direct microscopic observation of liquid cultures
S. Olaru-Peter, D. Diculencu, B. D. Grigoriu (Iasi, Romania)
| |
Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan
U. Kozhamkulov, A. Ahmetova, K. Momynaliev, S. Ismailov, A. Arike, E. Belova, C. Lailja, B. Venera (Astana, Almaty, Kazakhstan)
| |
Clinical, epidemiologic and social peculiarities of XDR pulmonary tuberculosis (PTB) patients
S. Skornyakov, D. Golubev, I. Motus, E. Kildyusheva (Yekaterinburg, Russian Federation)
| |
Long term treatment out come in multi drug resistant tuberculosis
R. Prasad, S. Verma, G. Hosmane, A. Singh, A. Jain, S. Verma, R. Garg, S. Anand (Lucknow, Kanpur, India)
| |
The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea
J. Kim, J. Suh, J. Kang, J. Kim, C. Park, K. Park, S. Lee, C. Kim, J. Ahn, Y. Kim, H. Moon (Incheon, , Seoul, Suwon, Republic Of Korea)
| |
Drug resistant tuberculosis in prison institutions of St. Petersburg, Russian Federation
K. Vladimirov, E. Zaitseva, A. Ivanov (St. Petersburg, Russian Federation)
| |
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity
A. Antunes, A. Aboim, A. Silva, R. Duarte (Vila Nova Gaia, Porto, Portugal)
| |